Descrizione business
CytoTools AG is a biotechnology company focused on translating fundamental biology research on the mechanisms of cell growth and programmed cell death into unique therapies that are designed to treat the cause of the disease rather than the symptoms. The Company has developed a robust and diverse pipeline of disease modifying therapies that comprise proprietary small molecules and biologics. These have the potential to provide new treatment options in dermatology, cardiology and angiology, urology and oncology.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Dr. Mark-Andre Freyberg |
| Consiglio di amministrazione |
| Marc Herwick, Dr. Dirk Kaiser |
| Consiglio di sorveglianza |
| Dr. Bernhard Seehaus, Dr. Manfred May, Dr. Rüdiger Weseloh, Heiner Hoppmann, Matthias Hoffmann |
Dati aziendali
| Name: |
CytoTools AG |
| Indirizzo: |
Klappacher Straße 126,D-64285 Darmstadt |
| Telefono: |
+49-6151-951-5812 |
| Fax: |
+49-6151-951-5813 |
| E-mail: |
kontakt@cytotools.de
|
| Internet: |
www.cytotools.de/ |
| Industria: |
Biotechnology |
| Settore: |
Biotechnology |
| Sub settore: |
Biotechnology |
| Fine dell'anno finanziario: |
31/12 |
| Flottante libero: |
53.00% |
| Data dell'IPO: |
- |
Rapporti con gli investitori
| Name: |
Dr. Mark-Andre Freyberg |
| IR telefono: |
- |
| IR Fax: |
- |
| IR e-mail: |
-
|
